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Granulomatosis with polyangiitis (GPA) is a rare form of vasculitis. Multidisciplinary therapeutic
approach and early diagnosis assume vital importance in management of patients with diffuse alveolar
haemorrhage caused by GPA, which is a rare complication. The purpose of this study was to present the
diagnostic and therapeutic challenges experienced by clinicians in management of two severe cases of
GPA with insidious extrapulmonary manifestations which rapidly progressed into acute kidney injury,
alveolar haemorrhage and acute respiratory failure.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Granulomatosis with polyangiitis (GPA), formerly known as
Wegener's granulomatosis, is a form of vasculitis which belongs to
the group of anti-neutrophil cytoplasmic antibody (ANCA)-associ-
ated vasculitides. It is rare systemic disease which involves small
size vessels and is characterised by necrotising granulomatous
inﬂammation [1]. Its clinical picture and prognosis may vary with
the affected organ system. At the outset, it may follow amild course
with non-speciﬁc constitutional symptoms. However, it may
rapidly progress into involvement of vital organs, causing fatal
outcomes.
Despite the commonly used criteria, diagnosis of vasculitis re-
mains under debate [2,3]. In diagnosis of GPA, clinicians should
suspect vasculitis ﬁrst and establish the diagnosis based on a
combination of clinical assessment, radiologic evidence, serological
tests and tissue biopsy, wherever applicable. In the updated deﬁ-
nitions of vasculitis, ANCA serology is mentioned as one of the
diagnostic criterion for GPA and recognised as a diagnostic value
because a positive c-ANCA (cytoplasmic) serology may provide
diagnosis of GPA without further requirement for biopsy in some
patients [3].
Diffuse alveolar haemorrhage (DAH) is a clinical syndrome
which can be fatal if not diagnosed properly and treated in time.
DAH, which may be caused by a number of factors, is rare: þ90 4122488523.
).
Ltd. This is an open access article udeterminant of poor prognosis in patients with GPA and a precursor
of early mortality [4,5].
The purpose of this study was to present the diagnostic and
therapeutic challenges experienced by clinicians in management of
two severe cases of GPA presenting with insidious extrapulmonary
ﬁndings which rapidly progressed into acute kidney injury (AKI),
DAH and severe acute respiratory failure (ARF).
Case reports
Case 1
A 60-year-old male patient presented to the emergency
department with complaints of rapid onset nausea and vomiting in
addition to fever and malaise over the last month. He carried no
previous diagnosis of any disease and was not on continuous
pharmacotherapy; however, he had a 10 pack-year history of
smoking (an ex-smoker of 25 years). Physical examination revealed
that his overall clinical status was moderate and he was conscious
and cooperative. His pulse rate was 95/min, his blood pressure was
130/80 mmHg, his respiratory rate was 16/min, his temperature
was 38.2 C and his oxygen saturation (SO2) level was 98% in room
air, as measured by pulse oxymetry. His complete blood count,
serum biochemistry, C-reactive protein (CRP) and erythrocyte
sedimentation rate (ESR) are demonstrated in Table 1. His urinalysis
showed 2 þ blood. Electrocardiogram, echocardiogram, abdominal
ultrasound and chest x-ray (CXR) showed no evidence of pathology
in the patient. Hewas transferred to Intensive Care Unit (ICU) of the
Nephrology Department due to fever of unknown origin andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Evolution of laboratory results of the cases with granulomatosis with polyangiitis.
Laboratory ﬁndings Case 1 (alive) Case 2 (death)
D0 D12 D22 D0 D7 D14
Hemoglobin (g/dl) 12.2 6.1 10.9 9.9 7.3 5.2
Haematocrit (%) 37.2 18.3 32.8 28.3 20.5 15.4
White blood cells (103/ml) 12.5 8.0 9.9 20. 18.3 15.7
Platelets (103/ml) 322. 341. 345. 604. 625. 565.
Serum urea (mg/dl) 172 70 70 106 99 179
Serum creatinine (mg/dl) 6.2 2.15 0.9 3.0 3.8 8.6
Serum potassium (mmol/l) 5.5 3.6 4.9 5.3 4.6 5.7
Serum albumin (g/dl) 2.75 2.4 3.5 1.5 1.5 1.6
C-reactive protein (mg/dl) 12.5 15.9 0.7 18 17 23
Erythrocyte sedimentation
rate (mm/h)
46 66 12 52 55 64
SO2 (%) (with pulse oxymetry
or ABG)
98a 85a 96a 93a 80b 95b
PaO2 (mm Hg) e 50 65 64 42 100
Bicarbonate (mmol/l) e 23 28 23 23 15
a Breathing room air.
b Breathing supplemental oxygen, D: Day, ABG: Arterial blood gases. SO2: Oxygen
saturation, PaO2: Partial oxygen pressure, PaCO2: Partial carbon dioxide pressure.
Fig. 1. Chest X-ray of Case 1 showing bilateral diffuse alveolar inﬁltrates (on the 12th
day of hospitalisation).
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supportive care, avoiding particularly nephrotoxic drugs. His 24-h
urine protein was 20 mg/dl.
The follow-up showed that the patient's renal functions
improved markedly and he required no dialysis. No bacterial
growth took place in his blood and urine cultures. Despite this good
prognosis, he developed minor haemoptysis, severe anaemia and
moderate hypoxaemia, as measured by the arterial blood gas
analysis (ABG) on the twelfth day of hospitalisation (Table 1). His
coagulation parameters were within the normal range. Urine
sedimentation examination demonstrated 20e25 red blood cells
and 6e8 leukocytes. In addition, CXR showed evidence of recently
developing bilateral diffuse alveolar inﬁltrates (Fig. 1). He was
transferred to respiratory ICU with a pre-diagnosis of DAH. Physical
examination revealed that he was dyspnoeic, tachypnoeic (28
breaths/min) and tachycardic (118 beats/min) and his SO2 level was
85%. Diffuse coarse crackles were heard in both sides of the lung in
osculation. He was diagnosed with ARF associated with DAH and
put on oxygen mask treatment at 10 1/min. However, this treat-
ment was replaced by non-invasive ventilation (NIV) as his clinical
status deteriorated. His blood pressure gradually increased and
saturation reached 96% in 24 h following initiation of the treatment.
Serological tests were requested for the patient on suspicion of
vasculitis and it was found that he was strongly c-ANCA positive,
antinuclear antibodies (ANA) negative, antiglomerular basal
membrane antibodies (anti-GBM) negative and peri-nuclear ANCA
(p-ANCA) negative. In addition, enzyme linked immunosorbent
assay showed high levels of serum anti-proteinase 3 antibody (anti-
PR3) titre. Fiberoptic bronchoscopy (FOB) was considered for deﬁ-
nite diagnosis; however it could not be performed due to the res-
piratory failure the patient suffered. The patient who was clinically
diagnosed with GPA was put on the following combined immu-
nosuppressive treatment: IV pulse cyclophosphamide (1 g/once)
and methylprednisolone (1 g/day) during the ﬁrst three days, fol-
lowed by methylprednisolone (1 mg/kg/day). Plasmaphaeresis was
administered simultaneously with the immunosuppressive treat-
ment, every day during the ﬁrst week.
The follow-up showed that his hypoxia and overall clinical
status improved. Therefore, dose of the oxygenation treatment was
reduced to 2 l/min and he was put on nasal cannula and inter-
mittent NIV. During hospital stay, he had no recurrent haemoptysis.
Serial CXR showed evidence of partial remission of bilateralinterstitial alveolar inﬁltrates. He required signiﬁcantly lesser
amount of oxygen and was transferred to the clinical department
and put on intermittent oxygen treatment at 2 l/min. Chest
computed tomography (CT) showed bilateral and extensive ground
glass opacities, interlobular septal thickening and mosaic perfusion
from place to place. On the 22nd day of hospitalisation, his clinical
status and laboratory results improved (Table 1) and he was
referred to a specialised rheumatology centre. Ear-nose-throat
(ENT) examination performed in that centre showed perforation
of nasal septum. Biopsy material taken from the patient was in
agreement with the diagnosis of GPA. In addition, renal biopsy
conﬁrmed that the patient had GPA with renal, pulmonary and
upper respiratory tract involvement. He was recommended daily
oral methylprednisolone and monthly IV cyclophosphamide
treatment. The patient, who is on immunosuppressive treatment,
has been followed up for four months now and no complications
have occurred in this period of time.
Case 2
A 48-year-old male patient presented to the emergency
department with fever, cough, bloody sputum, shortness of breath,
chest pain, nausea, vomiting, malaise, loss of appetite and articular
pain. He had antibiotic-resistant otitis media in the last three
months and respiratory symptoms over the last month. He was
referred to our hospital by another healthy facility due to evidence
of a mass lesion ﬁlling the left upper lobe (Fig. 2(a)) and bilateral
multiple nodules in the chest CT, which physicians thought could
be malignant. He was not on continuous pharmacotherapy; how-
ever he had a 30 pack-year history of smoking. Physical examina-
tion revealed that his overall clinical status was poor; he was
conscious but not fully cooperative. His pulse rate was 90/min, his
blood pressure was 120/70 mmHg, his respiratory rate was 15/min,
his body temperaturewas 37.8 C and his SO2 level was 93% in room
Fig. 2. a.) Mediastinal window of the chest computed tomography of Case 2 showing solid lesion ﬁlling the left apex. (b.) Purpuric lesions on the leg of Case 2 (vasculitic skin
involvement). (c.) Lung window of the chest computed tomography performed the day before Case 2 died.
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respiratory crackles. Routine laboratory ﬁndings are demonstrated
in Table 1. His coagulation parameters were within the normal
range. His urinalysis showed 100/ml of leukocytes, 75 mg/dl of
protein, 250 mg/l of blood. Electrocardiogram, echocardiogram and
abdominal ultrasound gave normal results. He was transferred to
respiratory ICU with a pre-diagnosis of AKI, ARF, sepsis, chronic
otitis media and suspected malignancy and put on supportive care
with oxygenation at 5 l/min, combined IV antibiotics (meropenem
and vancomisin) at renal dose, bronchodilatator and IV ﬂuid. His
24-h urine proteinwas 510 mg/dl. CT scan of bilateral temporal and
paranasal sinuses showed evidence of chronic sinusitis and cho-
lesteatoma in the right side.
On the second day of hospitalisation, consultation was reques-
ted from an ENT specialist who considered surgery indicated for the
patient due to paralysis of peripheral facial nerves and loss of
hearing, and the patient underwent radical mastoidectomy. On the
ﬁfth day of hospitalisation, purpuric rashes in both legs and trunk
were biopsied by a dermatologist (Fig. 2(b)).
On the seventh day of hospitalisation, FOB showed blood clots in
the trachea and main bronchi, and bronchoalveolar lavage (BAL)
revealed hemosiderin-ﬁlled macrophages. Urine sedimentation
examination showed erythrocyte cylinders. Diagnosis of DAH was
established based on the above mentioned ﬁndings and vasculitis
markers were requested to be checked. Nephrologists recom-
mended renal biopsy for the patient. However, his relatives did not
consent to the procedure. As to his serological tests, he was c-ANCA
positive, anti-PR3 positive, p-ANCA negative, anti-GBM negative
and ANA negative. Rheumatoid factor (RF) was found to be 250 IU/
ml (high) in the patient. His skin biopsy report indicatednecrotising leukocytoclastic vasculitis. He was diagnosed with GPA
based on positive c-ANCA serology, upper respiratory tract, pul-
monary and renal involvement and results of skin biopsy and
administered combined immunosuppressive treatment on the 10th
day of hospitalisation (IV pulse cyclophosphamide and high dose
pulse methylprednisolone). Two days later, he had to be treated
with dialysis as his clinical status and laboratory results deterio-
rated and he had acute metabolic acidosis, as shown by ABG
analysis. In addition, he was confused, tachypnoeic (38 breaths/
min), tachycardic (110 beats/min) and desaturated (SO2 75%). He
was put on invasive mechanical ventilation via endotracheal intu-
bation. Non-contrast chest CT showed recent evidence of bilateral
nodules as well as consolidation and multiple cavitary lesions with
thick walls particularly in the upper lobe of the left side, of which
the largest one was 5.5 cm. It was found that the solid mass lesion
detected in the previous CT had turned into a cavitating lesion
(Fig. 2(c)). On the 14th day of hospitalisation and the second day of
intubation, the patient had cardiopulmonary arrest and could not
be saved despite cardiopulmonary resuscitation attempts.
Discussion
Early diagnosis of GPA is not an easy task for clinicians. GPA
should be considered in the differential diagnosis of patients with
simultaneous or consecutive multiple organ involvement. Severity
of presenting symptoms and ﬁndings in patients with GPA may
vary considerably from asymptomatic (one third of patients) to
acute and fulminant alveolar haemorrhage with respiratory failure.
Typical early symptoms are fever, loss of weight and malaise;
however the disease is usually accompanied by upper and lower
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form of sinusitis, otitis media, cholesteotoma and loss of hearing
may occur in patients a few months before the manifestation of
pulmonary and renal problems [7]. In this study, Case 1 presented
with constitutional symptoms, followed by severe renal and pul-
monary involvement. Case 2, on the other hand, had prolonged ear-
nose-throat symptoms, followed by pulmonary, renal and skin
involvement. At the outset, insidious nature of the disease and local
presentationmay delay the diagnosis, whichwas exactly the case in
our patients.
Diffuse alveolar haemorrhage should be considered a medical
emergency. Although it occurs only in 5e10% of patients with GPA,
it usually acts as a precursor of severe vasculitis. In addition, mor-
tality remains high in these patients due to ARF associated with
DAH. Clinicians should suspect DAH in the event of haemoptysis, a
sudden drop in haemoglobin levels and recently developing in-
ﬁltrates in CXR. It should also be kept in mind that haemoptysis
may be absent at presentation in up to 33% of patients with DAH. In
these patients, the most common indications for FOB are to assess
the airway and perform BAL as ﬁndings of BAL form the basis for a
deﬁnite diagnosis of DAH [4]. In this study, Case 1 had no respira-
tory symptoms on admission. Later on, he had minor haemoptysis
and sudden onset anaemia and recently developing inﬁltrates in
CXR. Based on these ﬁndings, he was diagnosed with DAH. Case 2,
on the other hand, was referred to our hospital by another health
facility due to respiratory symptoms he was complaining about
over the last month and suspected malignancy in CT. On admission,
he hadminor haemoptysis andmild hypoxaemia. His clinical status
deteriorated in the hospital and he died despite the use of invasive
mechanical ventilation. FOB could not be performed in Case 1
because of the severe ARF he suffered. In Case 2, cytology of BAL
conﬁrmed the diagnosis of DAH.
Renal involvement is common in patients with GPA. It may
occur either at the outset or during the course of the disease. It can
present as asymptomatic haematuria or AKI with haematuria and
cellular casts. Proteinuria varies in degree and is usually sub-
nephrotic. Serum creatinine test should be run in all patients for
determination of a potential kidney injury [8]. In this study, Case 1
had a high serum ceratinine level and microscopic haematuria on
admission. He had no signiﬁcant proteinuria in the 24-h urine
protein test. AKI that the patient was suffering improved sponta-
neously without requirement for dialysis. Case 2, on the other hand,
had a high serum creatinine level, abnormal urinalysis results and
subnephrotic range proteinuria. Renal failure deteriorated in this
patient despite themultidisciplinary therapeutic approach that was
adopted.
It was reported in the literature and also shown by the present
study that c-ANCA and anti-PR3 positivity was most consistent
with GPA (90% of patients) [3]. In addition to ANCA testing, other
laboratory analyses (such as ANA, anti-GBM, cryoglobulins, hepa-
titis serology, HIV screening, liver function tests and blood cultures)
should also be performed in patients with GPA to assess the po-
tential involvement of other organs and exclude other processes in
differential diagnosis. Common haematologic abnormalities in GPA
include anaemia, leucocytosis, thrombocytosis and markedly
elevated levels of ESR and CRP. Rheumatoid factor is positive in
50e60% of patients [6]. In-hospital risk of mortality is quite high
among the elderly with serum albumin levels <2.0 g/dl [9]. As
demonstrated in Table 1, on admission Case 1 had high levels of
leukocytes, urea, ceratinine, potassium, CRP and ESR and a low level
of albumin in serum. His clinic status markedly improved following
the proper treatment. Case 2, on the other hand, had high levels of
leukocytes, thrombocytes, urea, ceratinine, potassium, CRP and ESR
and low levels of haemoglobin and albumin in serum. He had a
positive RF test. In addition, he had exitus despite his relative youngage. We believe that low serum levels of albumin may have been a
marker of mortality in this patient.
Chest X-ray and CT should be performed in all patients who have
pulmonary symptoms and are suspected of having GPA. A vast
majority of patients with GPA have abnormalities in CXR. Radio-
graphic ﬁndings usually include at least one of the following:
cavitary nodules, diffuse hazy opacities, lobar or segmental atel-
ectasis, pleural opacities and rarely hilar adenopathy. Chest CT is
helpful in exposing the lesions which cannot be seen in CXR and
identifying cavitationwhich was not suspected previously. Nodules
may range in size from a fewmillimetres to 10 cm [10]. In this study,
Case 1 had normal CXR ﬁndings on admission but developed
bilateral diffuse opacities in the post-haemoptysis period. Case 2,
on the other hand, had a mass lesion and multiple nodules which
looked suspicious on admission. Follow-up CT showed that some of
the nodules became cavitary in time.
Given the potential toxicity of the treatment, it is ideal to
conﬁrm the diagnosis of GPA by means of tissue biopsy even in
patients with a compatible clinical presentation and positive ANCA
serology. Biopsy site should be chosen based on the accessibility of
speciﬁc sites of the disease and tolerability of the planned proce-
dure by the patient. Skin biopsy generally shows non-speciﬁc leu-
kocytoclastic vasculitis. Although it is relatively non-invasive, nasal
biopsy is limited by the high rate of false negativity. Kidney biopsy
typically shows segmental necrotizing glomerulonephritis, usually
with crescents. The main indication for lung biopsy is to assess
single or multiple pulmonary nodules, especially when extrap-
ulmonary disease is not present or not accessible to biopsy [11]. In
this study, Case 1 was diagnosed based on clinical, radiological and
serological ﬁndings and administered an aggressive treatment. The
diagnosis was conﬁrmed by nasal renal biopsy that was performed
in the health facility where he was being followed-up. In Case 2, on
the other hand, deﬁnite diagnosis was established by skin biopsy.
In patients with GPA, conventional induction therapy usually
consists of high dose glucocorticoids and cyclophosphamide [5].
When administered shortly after the induction therapy, combined
immunosuppressive therapy ensures remission in up to 90% of
patients within 6 months [12]. Plasmaphaeresis reduces the
amount of circulating ANCA in the body. Given the high mortality
rates (up to 50%), patients with ARF associated with DAH should
soon be administered immunosuppressive therapy simultaneously
with plasmaphaeresis [13]. In this study, Case 1 was successfully
administered a combination of plasmaphaeresis and immunosup-
pressive therapy. However, plasmaphaeresis could not be per-
formed in Case 2 as he was hemodynamically unstable.
Patients with GPA who develop respiratory failure, severe hae-
moptysis, sepsis, acute renal failure and gastrointestinal bleeding
must be followed up in the intensive care unit. Pulmonary mani-
festations (severe haemoptysis and respiratory failure) have a
particular association with survival in these patients [14]. In this
study, both of the cases developed severe respiratory failure.
However, Case 1 showed marked improvement following NIV and
did not require oxygenation after he was discharged from the
hospital whereas Case 2 showed no improvement possibly due to
such negative factors as history of heavy smoking, sepsis and
metabolic acidosis.
In conclusion, clinical presentation and course may vary greatly
in GPA and clinical suspicion is the most important factor for its
diagnosis. DAHmay lead to vital outcomes in patients with GPA due
to high risk of mortality caused by ARF associated with DAH, which
is a rare complication. Biopsy may not be applicable in patients
with DAH; however BAL e a minimally invasive procedure-should
be performed for deﬁnite diagnosis, and proper treatment should
soon be administered in these patients who are in need of intensive
care. Lastly, clinicians must be aware of the diagnostic challenges of
H. Kaya et al. / Respiratory Medicine Case Reports 13 (2014) 32e3636GPA and adopt a multidisciplinary approach in management of
patients with GPA.
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